IGC Pharma, Inc. (IGC) — Net Income

Annual figures by fiscal year, from SEC filings.

2011: -$20.24M2012: -$7.75M2013: -$2.25M2014: -$3.02M2015: -$4.61M2016: -$2.81M2017: -$1.87M2018: -$1.79M2019: -$4.10M2020: -$7.32M2021: -$8.81M2022: -$15.02M2023: -$11.51M2024: -$13.00M2025: -$7.12M-$7.12M
2011Net Income (USD)2025
Fiscal YearNet IncomeChange YoY
2025-$7.12M+45.2%
2024-$13.00M-13.0%
2023-$11.51M+23.4%
2022-$15.02M-70.4%
2021-$8.81M-20.5%
2020-$7.32M-78.5%
2019-$4.10M-129.4%
2018-$1.79M+4.4%
2017-$1.87M+33.5%
2016-$2.81M+39.1%
2015-$4.61M-52.7%
2014-$3.02M-34.2%
2013-$2.25M+70.9%
2012-$7.75M+61.7%
2011-$20.24M